Feldman & Pinto

Banner

  • Home
  • About Us
  • Practice Areas
  • Case Investigations
  • News
    • Firm News
    • Law News
  • Contact Us

News

Latest Firm News

  • Paxil Cases Assigned to Savage, Over GlaxoSmithKline's Protests

     

    U.S. District Judge Timothy J. Savage


    U.S. District Judge Timothy J. Savage  (Image: Handout)

    In a setback for GlaxoSmithKline, the same federal judge who recently remanded eight Paxil birth defect suits to state court has now been assigned by his chief judge to decide the fate of another 21 cases despite GSK's protests of "judge shopping."

     

    Read more
  • Bayer's Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot

     PHILADELPHIA, April 22, 2011 /PRNewswire-USNewswire/ -- The following release is being issued by law firms RodaNast, P.C.; Levin, Fishbein, Sedran & Berman and Feldman & Pinto:

    According to two new studies published in the online edition of the British Medical Journal, Bayer's birth control pills Yaz and Yasmin, containing a new progestin drospirenone (DSRP), carry up to triple the risk of serious blood clots (known as venous thromboembolism) over traditional pills containing the progestin levonorgestrel (LNG).Read more

Latest Law News

  • FDA Reviewing Stronger Warning Labels Regarding Blood Clots on Yaz Labels

    The Associated Press as well as ABC Nighty News Have Recently Published Articles Highlighting the FDA's Desire to Add Additional Safety Warnings to Yaz Labels:

    {youtube}DVy-uDadBx4{/youtube}

    "Federal health regulators are leaning toward adding new information about the risk of blood clots to the labels of widely prescribed birth control pills such as Yaz, in light of growing evidence suggesting the newer contraceptive drugs may be riskier than older drugs. In documents released Tuesday, the Food and Drug Administration said there is conflicting evidence about the risk from several studies, but the information should appear in labeling used by doctors and patients.Read more

  • Asthma Relieving Advair Linked to Severe Asthma Attacks

    Manufactured in 2000 by GlaxoSmithKline, Advair an inhaled medication, contains both Long-Acting Beta-Agonists, fluticasone propionate (Flovent) and salmeterol (Serevent).This combination treatment decreases inflammation in the lungs, and works to relax the muscles around the airways in the lungs. Advair is primarily used to treat asthma attacks and chronic pulmonary disease.Read more

  • Hot Coffee Trailer

    Susan Saladoff has released the official trailer for her documentary "Hot Coffee". This documentary discusses the media's role in corporate America. {youtube}bBKRjxeQnT4{/youtube}

    The makers of  "Hot Coffee" have also provided a link that shows various steps you can take to protect your access to the civil justice system:

    • http://www.youtube.com/watch?v=pucsJTFe548

    Enjoy!

More News

Firm News | Law News

Latest Firm News

  • Paxil Cases Assigned to Savage, Over GlaxoSmithKline's Protests 
  • Bayer's Yaz and Yasmin Birth Control Pills Have an Increased Risk of Blood Clot 
  • Pennsylania Poised to be Center of State Court Yaz and Yasmin Birth Control Litigation 
  • Laura Feldman Honored by Philadelphia VIP 

Latest Law News

  • FDA Reviewing Stronger Warning Labels Regarding Blood Clots on Yaz Labels  
  • Hot Coffee Trailer 
  • Meme-Busting: Tort Reform = Cost Control 
  • FDA Warns Not to Feed Simply Thick to Premature Infants  
  • Birth Control Pills Containing Drospirenone: Possible Increased Risk of Blood Clots  
  • Paxil Cases Assigned to Savage, Over GlaxoSmithKline's Protests 
  • Judge Rules GSK's 'Nerve Center' in Phila. for Paxil Suits 
  • Oral Contraceptives and the Risk of Gall Bladder Disease: A Comparative Safety Study 
  • Asthma Relieving Advair Linked to Severe Asthma Attacks 
  • Wicked Understudy Sues Bayer Claiming Yasmin Caused Stroke 
  • Zicam Not Alone in Reports of Side Effects 
  • Yaz & The New York Times  
  • Paxil Related Birth Defects 
  • Early Cancer Diagnosis 
  • Diabetic Footcare 
  • Fines Unlikely to End Off-Label Drug Marketing 
  • Pfizer Expected to Pay Record Settlement to U.S. 
  • High Stakes for Merck in Litigation on Fosamax 
  • Bausch & Lomb Beats Back Lens-Cleaner Lawsuits 
  • 13 Years Later, Medical Malpractice Case Settled 


  • Home
  • About Us
  • Practice Areas
  • Case Investigations
  • News
  • Contact Us

All website content ©2013 Feldman & Pinto, All Rights Reserved | Contact Feldman & Pinto

FELDMAN & PINTO, ATTORNEYS AT LAW. 1604 Locust St, 2R  ·  Philadelphia, PA 19103  ·  Phone: 215-546-2604  ·  Fax: 215-546-9904

Disclaimer: Submissions of information through our online feature does not guarantee or create an attorney-client relationship between Feldman & Pinto and the person or entity submitting information. Feldman & Pinto will treat all submissions as confidential; however, we cannot guarantee the security of all online transmissions.